Analysts Set Trupanion, Inc. (NASDAQ:TRUP) Price Target at $41.60

Trupanion, Inc. (NASDAQ:TRUP) has been assigned an average recommendation of “Hold” from the six research firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $41.60.

A number of research firms have recently weighed in on TRUP. Bank of America dropped their target price on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a report on Tuesday, April 14th. Stifel Nicolaus set a $28.00 price target on Trupanion in a report on Friday, June 26th. Atlantic Securities set a $42.00 price target on Trupanion in a research report on Wednesday. Cantor Fitzgerald dropped their price objective on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st.

Insider Activity at Trupanion

In related news, CFO Fawwad Qureshi sold 6,177 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total transaction of $137,005.86. Following the completion of the transaction, the chief financial officer owned 2,081 shares in the company, valued at $46,156.58. This represents a 74.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO John R. Gallagher sold 3,603 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $21.69, for a total transaction of $78,149.07. Following the transaction, the chief operating officer directly owned 33,065 shares in the company, valued at approximately $717,179.85. The trade was a 9.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 17,807 shares of company stock worth $395,482 over the last quarter. 5.58% of the stock is owned by corporate insiders.

Institutional Trading of Trupanion

Several institutional investors and hedge funds have recently bought and sold shares of TRUP. Thrivent Financial for Lutherans lifted its position in Trupanion by 1.1% during the second quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock valued at $1,376,000 after purchasing an additional 282 shares in the last quarter. EP Wealth Advisors LLC increased its position in Trupanion by 2.9% in the second quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock worth $571,000 after buying an additional 292 shares in the last quarter. Illinois Municipal Retirement Fund increased its position in Trupanion by 2.3% in the first quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider’s stock worth $456,000 after buying an additional 406 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Trupanion by 2.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 33,657 shares of the financial services provider’s stock worth $1,258,000 after buying an additional 725 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Trupanion by 3.8% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider’s stock worth $1,126,000 after buying an additional 737 shares during the period.

Trupanion Stock Up 1.3%

Shares of NASDAQ TRUP opened at $26.70 on Thursday. The firm’s fifty day moving average is $23.83 and its 200 day moving average is $27.31. Trupanion has a 52 week low of $21.16 and a 52 week high of $57.00. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25. The company has a market cap of $1.16 billion, a price-to-earnings ratio of 45.25 and a beta of 1.39.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.04. The business had revenue of $384.05 million during the quarter, compared to analysts’ expectations of $379.77 million. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The firm’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.03) EPS. On average, equities research analysts expect that Trupanion will post 0.55 earnings per share for the current year.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.